Target
Alpha-2B adrenergic receptor
Ligand
BDBM50253157
Substrate
n/a
Meas. Tech.
ChEMBL_1804493 (CHEMBL4303096)
Ki
479±n/a nM
Citation
 Gordon, DEJang, GMBouhaddou, MXu, JObernier, KWhite, KMO'Meara, MJRezelj, VVGuo, JZSwaney, DLTummino, TAHüttenhain, RKaake, RMRichards, ALTutuncuoglu, BFoussard, HBatra, JHaas, KModak, MKim, MHaas, PPolacco, BJBraberg, HFabius, JMEckhardt, MSoucheray, MBennett, MJCakir, MMcGregor, MJLi, QMeyer, BRoesch, FVallet, TMac Kain, AMiorin, LMoreno, ENaing, ZZCZhou, YPeng, SShi, YZhang, ZShen, WKirby, ITMelnyk, JEChorba, JSLou, KDai, SABarrio-Hernandez, IMemon, DHernandez-Armenta, CLyu, JMathy, CJPPerica, TPilla, KBGanesan, SJSaltzberg, DJRakesh, RLiu, XRosenthal, SBCalviello, LVenkataramanan, SLiboy-Lugo, JLin, YHuang, XPLiu, YWankowicz, SABohn, MSafari, MUgur, FSKoh, CSavar, NSTran, QDShengjuler, DFletcher, SJO'Neal, MCCai, YChang, JCJBroadhurst, DJKlippsten, SSharp, PPWenzell, NAKuzuoglu-Ozturk, DWang, HYTrenker, RYoung, JMCavero, DAHiatt, JRoth, TLRathore, USubramanian, ANoack, JHubert, MStroud, RMFrankel, ADRosenberg, OSVerba, KAAgard, DAOtt, MEmerman, MJura, Nvon Zastrow, MVerdin, EAshworth, ASchwartz, Od'Enfert, CMukherjee, SJacobson, MMalik, HSFujimori, DGIdeker, TCraik, CSFloor, SNFraser, JSGross, JDSali, ARoth, BLRuggero, DTaunton, JKortemme, TBeltrao, PVignuzzi, MGarcía-Sastre, AShokat, KMShoichet, BKKrogan, NJ A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583:459-468 (2020) [PubMed]  Article 
Target
Name:
Alpha-2B adrenergic receptor
Synonyms:
ADA2B_HUMAN | ADRA2B | ADRA2L1 | ADRA2RL1 | Adrenergic alpha2B | Adrenergic receptor | Adrenergic receptor alpha | Adrenergic, alpha-2B-, receptor [Homo sapiens] | Alpha-2 adrenergic receptor subtype C2 | Alpha-2B adrenoceptor | Alpha-2B adrenoreceptor | Alpha-2BAR
Type:
Enzyme
Mol. Mass.:
49964.20
Organism:
Homo sapiens (Human)
Description:
P18089
Residue:
450
Sequence:
MDHQDPYSVQATAAIAAAITFLILFTIFGNALVILAVLTSRSLRAPQNLFLVSLAAADILVATLIIPFSLANELLGYWYFRRTWCEVYLALDVLFCTSSIVHLCAISLDRYWAVSRALEYNSKRTPRRIKCIILTVWLIAAVISLPPLIYKGDQGPQPRGRPQCKLNQEAWYILASSIGSFFAPCLIMILVYLRIYLIAKRSNRRGPRAKGGPGQGESKQPRPDHGGALASAKLPALASVASAREVNGHSKSTGEKEEGETPEDTGTRALPPSWAALPNSGQGQKEGVCGASPEDEAEEEEEEEEEEEECEPQAVPVSPASACSPPLQQPQGSRVLATLRGQVLLGRGVGAIGGQWWRRRAQLTREKRFTFVLAVVIGVFVLCWFPFFFSYSLGAICPKHCKVPHGLFQFFFWIGYCNSSLNPVIYTIFNQDFRRAFRRILCRPWTQTAW
  
Inhibitor
Name:
BDBM50253157
Synonyms:
(+)-(2R)-2-(2-(((R)-p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine | (+)-(2R)-2-[2-[[(R)-p-chloro-alpha-methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine | (2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine | CHEMBL1626 | CLEMASTINE
Type:
Small organic molecule
Emp. Form.:
C21H26ClNO
Mol. Mass.:
343.89
SMILES:
CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1 |r|
Structure:
Search PDB for entries with ligand similarity: